Balance Risks and Benefits of Antithrombotic Combos in Atrial Fib

Antithrombotic combos for patients with atrial fib PLUS a coronary stent are a moving target...due to evolving evidence and stent technology.

The standard used to be "triple therapy"...an anticoagulant (warfarin, etc) plus TWO antiplatelets (aspirin and clopidogrel, etc).

But these combos are a tightrope walk...and risk of bleeding must be balanced against risk of embolic stroke, MI, or stent thrombosis.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

  • 12 issues every year, with brief articles about new meds and guidelines
  • 48+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote